Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat
- 1 July 2008
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 295 (1) , E103-E109
Abstract
Angiotensin II (Ang II) stimulation of the Ang type 1 receptor (AT1R) facilitates myocardial remodeling through NADPH oxidase-mediated generation of oxidative stress. Components of the renin-angiotensin system constitute an autocrine/paracrine unit in the myocardium, including renin, which is the rate-limiting step in the generation of Ang II. This investigation sought to determine whether cardiac oxidative stress and cellular remodeling could be attenuated by in vivo renin inhibition and/or AT1R blockade in a rodent model of chronically elevated tissue Ang II levels, the transgenic (mRen2)27 rat (Ren2). The Ren2 overexpresses the mouse renin transgene with resultant hypertension, insulin resistance, and cardiovascular damage. Young (6- to 7-wk-old) heterozygous (+/−) male Ren2 and age-matched Sprague-Dawley rats were treated with the renin inhibitor aliskiren, which has high preferential affinity for human and mouse renin, an AT1R blocker, irbesartan, or placebo for 3 wk. Myocardial NADPH oxidase activity and immunostaining for NADPH oxidase subunits and 3-nitrotyrosine were evaluated and remodeling changes assessed by light and transmission electron microscopy. Blood pressure, myocardial NADPH oxidase activity and subunit immunostaining, 3-nitrotyrosine, perivascular fibrosis, mitochondrial content, and markers of activity were significantly increased in Ren2 compared with SD littermates. Both renin inhibition and blockade of the AT1R significantly attenuated cardiac functional and structural alterations, although irbesartan treatment resulted in greater reductions of both blood pressure and markers of oxidative stress. Collectively, these data suggest that both reduce changes driven, in part, by Ang II-mediated increases in NADPH oxidase and, in part, increases in blood pressure.Keywords
This publication has 47 references indexed in Scilit:
- Role of Mitochondrial Dysfunction in Insulin ResistanceCirculation Research, 2008
- Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 ratAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Aliskiren Reduces Blood Pressure and Suppresses Plasma Renin Activity in Combination With a Thiazide Diuretic, an Angiotensin-Converting Enzyme Inhibitor, or an Angiotensin Receptor BlockerHypertension, 2007
- Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusionJournal of Clinical Investigation, 2006
- Increased Aortic NADPH Oxidase Activity in Rats With Genetically High Angiotensin-Converting Enzyme LevelsHypertension, 2005
- Redox regulation of angiotensin II siganling in the heartJournal of Cellular and Molecular Medicine, 2004
- AT 1 Blockade Prevents Glucose-Induced Cardiac Dysfunction in Ventricular MyocytesHypertension, 2003
- Reduction in Left Ventricular Messenger RNA for Transforming Growth Factor β 1 Attenuates Left Ventricular Fibrosis and Improves Survival Without Lowering Blood Pressure in the Hypertensive TGR(mRen2)27 RatHypertension, 2000
- Angiotensin and Bradykinin Peptides in the TGR(mRen-2)27 RatHypertension, 1995
- Differential Gene Expression of Renin and Angiotensinogen in the TGR(mREN-2)27 Transgenic RatHypertension, 1995